Bio Green Med Solution, Inc. (BGMSP) Stock Price & Analysis
Bio Green Med Solution, Inc. (BGMSP) fell 30.00% to USD 0.7 as of June 10, 2026 at 05:56 UTC, according to Nexqual real-time market data.
BGMSP last closed at USD 1; the session ranged USD 0.7–0.7 on volume of 2,592 shares. Market capitalization is —, with a 52-week range of USD 0.3–14 (PNK). Source: Nexqual, June 10, 2026 at 05:56 UTC.
Key Statistics (as of June 10, 2026 at 05:56 UTC)
| Price | USD 0.7 |
|---|---|
| Change | ▼ 30.00% (down) |
| Previous Close | USD 1 |
| Open | USD 0.7 |
| Day Range | USD 0.7 – 0.7 |
| 52-Week Range | USD 0.3 – 14 |
| Volume | 2,592 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (BGMSP)
Nexqual's technical model rates BGMSP "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 05:56 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 36.83 (neutral) |
| vs SMA50 | Below (USD 0.95) |
| MACD | -0.12 (negative) |
Analyst Ratings (BGMSP)
Wall Street analysts rate BGMSP "None", per Nexqual as of June 10, 2026 at 05:56 UTC.
| Consensus Rating | None |
|---|
Earnings (BGMSP)
Source: Nexqual, June 10, 2026 at 05:56 UTC.
Financials & Fundamentals (BGMSP)
| Total Revenue | $1.52M |
|---|---|
| Gross Margin | -34.75% |
| Operating Margin | -31.62% |
| Profit Margin | -204.20% |
| ROE | +20.59% |
| Current Ratio | 7.06 |
| Total Cash | $3.34M |
| Total Debt | $0 |
Source: Nexqual, June 10, 2026 at 05:56 UTC.
Financial Health Score (BGMSP)
Nexqual rates Bio Green Med Solution, Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 05:56 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $3M cash, no debt |
| Cash Flow | Mixed — No data |
| Efficiency | Strong — ROE 21%, ROA -49.3% |
Ownership (BGMSP)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +1.39% |
| Float | 3.42M |
Source: Nexqual, June 10, 2026 at 05:56 UTC.
Leadership (BGMSP)
Bio Green Med Solution, Inc. is led by Sing Ee Wong (age 44), Chairman, CEO & President, per Nexqual as of June 10, 2026 at 05:56 UTC.
| Chairman, CEO & President | Sing Ee Wong (age 44) |
|---|---|
| Executive Director, CFO & Secretary | Cu Seng Kiu (age 35) |
| Director of Human Resources | Gill Christie (age 68) |
Major Backers & Investors (BGMSP)
Notable institutional backers of Bio Green Med Solution, Inc. include Vsm Wealth Advisory, LLC , according to Nexqual as of June 10, 2026 at 05:56 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Vsm Wealth Advisory, LLC | 1.39% |
Source: Nexqual, June 10, 2026 at 05:56 UTC.
From Bio Green Med Solution, Inc.'s Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CSCIF | COSCIENS Biopharma Inc | USD 2.05 | ▲ 12.64% |
| CLRB | Cellectar Biosciences, Inc. | USD 2.36 | ▼ 8.88% |
| MBRX | Moleculin Biotech, Inc. | USD 2.41 | ▲ 0.42% |
| CRIS | Curis, Inc. | USD 0.45 | ▼ 4.87% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:56 UTC. This page is informational and not investment advice.